相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Merin E. Kuruvilla et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life
Carlo Lombardi et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
Hector Ortega et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
I have lost in every facet of my life: the hidden burden of severe asthma
Juliet M. Foster et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Severe asthma and quality of life
Elham Hossny et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2017)
Effects of conventional tobacco smoke and nicotine-free cigarette smoke on airway inflammation, airway remodelling and lung function in a triple allergen model of severe asthma
C. Tilp et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
Njira Lugogo et al.
CLINICAL THERAPEUTICS (2016)
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
M. Caminati et al.
BMC PULMONARY MEDICINE (2016)
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
Hector G. Ortega et al.
LANCET RESPIRATORY MEDICINE (2016)
The prevalence of severe refractory asthma
Pieter-Paul W. Hekking et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol
Emma S. Chambers et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
Stephen O'Neill et al.
THORAX (2015)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)
F. Schleich et al.
RESPIRATORY MEDICINE (2014)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Patrick Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
How representative are clinical study patients with asthma or COPD for a larger real life population of patients with obstructive lung disease?
K Herland et al.
RESPIRATORY MEDICINE (2005)
分享论文
